Cite
Liposomal irinotecan plus fluorouracil/leucovorin in older patients with advanced pancreatic cancer: a single-center retrospective study.
MLA
Nagashima, Shuhei, et al. “Liposomal Irinotecan plus Fluorouracil/Leucovorin in Older Patients with Advanced Pancreatic Cancer: A Single-Center Retrospective Study.” International Journal of Clinical Oncology, vol. 29, no. 2, Feb. 2024, pp. 188–94. EBSCOhost, https://doi.org/10.1007/s10147-023-02432-9.
APA
Nagashima, S., Kobayashi, S., Tsunoda, S., Yamachika, Y., Tozuka, Y., Fukushima, T., Morimoto, M., Ueno, M., Furuse, J., & Maeda, S. (2024). Liposomal irinotecan plus fluorouracil/leucovorin in older patients with advanced pancreatic cancer: a single-center retrospective study. International Journal of Clinical Oncology, 29(2), 188–194. https://doi.org/10.1007/s10147-023-02432-9
Chicago
Nagashima, Shuhei, Satoshi Kobayashi, Shotaro Tsunoda, Yui Yamachika, Yuichiro Tozuka, Taito Fukushima, Manabu Morimoto, Makoto Ueno, Junji Furuse, and Shin Maeda. 2024. “Liposomal Irinotecan plus Fluorouracil/Leucovorin in Older Patients with Advanced Pancreatic Cancer: A Single-Center Retrospective Study.” International Journal of Clinical Oncology 29 (2): 188–94. doi:10.1007/s10147-023-02432-9.